Log in
/
English
Polski
Español
українська
Toggle navigation
Textbook
Sections
Diseases
Noninvasive Diagnostic Tests
Procedures
Signs and Symptoms
Trauma and Injuries
Acute and Critical Medical Care
Abbreviations
CME
GRADE
Chapters
Course
What’s New
Interviews
McMaster Perspective
Cardiology
Endocrinology
Gastroenterology
Hematology
ICU & Emergencies
Infectious Diseases
Nephrology
Neurology
Oncology
Respirology
Rheumatology
Toxicology
VTE
Other
Lectures
Refreshers
Articles
Resources
Editorial Board
Mobile
Sponsors
Diseases
Allergy & Immunology
Cardiovascular Diseases
Dermatology
Endocrinology
Fluids, Electrolytes, Acids, Bases
Gastroenterology
Geriatrics
Hematology
Infectious Diseases
Nephrology
Neurology
Palliative Care
Poisonings & Intoxications
Psychiatry
Respiratory Diseases
Rheumatology
Noninvasive Diagnostic Tests
Procedures
Signs & Symptoms
Trauma & Injuries
Acute & Critical Medical Care
Abbreviations
CME
GRADE
Log in
/
McMaster Textbook of Internal Medicine
Interviews
VTE
Management of patients treated with novel oral anticoagulants who require surgery
Management of patients treated with novel oral anticoagulants who require surgery
2015-06-05
James Douketis
See also
D-dimer concentrations and discontinuation of anticoagulants following a thrombotic event
Should the D-dimer concentration be taken into account when considering discontinuation of anticoagulants following a thrombotic event?
Approaching a patient on novel oral anticoagulants who develops bleeding or requires an urgent surgery
How to approach a patient treated with novel oral anticoagulants who develops bleeding or in whom an urgent surgery is necessary?
We would love to hear from you
Comments, mistakes, suggestions?
Send feedback
Social Media